ArticleHuman gene therapy. Clinical development2016

Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.

Daxa M Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.